Slideshow
ACC 2017: CV Risk Factors
Author(s):
Research includes a possible link between Zika & CV issues, CV effects of cannabis use, and neurocognitive impairment with PCSK9 variants.
Presentations at the American College of Cardiology’s Annual Scientific Sessions included potential heart issues related to Zika infection, risk of stroke and heart failure with cannabis use, and neurocognitive impairment with PCSK9 variants.
ACC 2017: CV Risk Factors
Related Videos
Tailoring Precision Medicine Treatment of Hemorrhagic Stroke Through Predictive Models: Kara R. Melmed, MD
Enhancing Brain Plasticity by Personalized and Closed-Loop Neuromodulation: Roy H. Hamilton, MD, MS, FAAN
Evolving Evidence and Clinical Confidence for Blood Pressure Management in Intracerebral Hemorrhage: Chitra Venkatasubramanian, MBBS, MD, MSc, FNCS
Exploring Noninvasive Brain Stimulation for Neurorehabilitation: Roy H. Hamilton, MD, MS, FAAN
The Key Role of Early and Balanced Blood Pressure Control in ICH Management: Kara R. Melmed, MD
Aggressive Blood Pressure Lowering for Intracerebral Hemorrhage Management: Chitra Venkatasubramanian, MBBS, MD, MSc, FNCS
Nuances in Thrombectomy Techniques and Anesthesia Use for Stroke: J Mocco, MD, MS
Innovation in Stroke Care and Expanding the Treatment Windows: Keith Churchwell, MD, FAHA, FACC, FACP
Lessons Learned From the 2025 International Stroke Conference: Keith Churchwell, MD, FAHA, FACC, FACP
Key Considerations When Incorporating Stroke Trial Data Into Clinical Practice: J Mocco, MD, MS
Related Content
